✦ LIBER ✦

Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial

✍ Scribed by Derek J. Hausenloy; Luciano Candilio; Chris Laing; Gudrun Kunst; John Pepper; Shyam Kolvekar; Richard Evans; Steve Robertson; Rosemary Knight; Cono Ariti; Tim Clayton; Derek M. Yellon; The ERICCA Trial Investigators

Book ID: 113037163
Publisher: Springer
Year: 2011
Tongue: English
Weight: 256 KB
Volume: 101
Category: Article
ISSN: 1861-0684
DOI: 10.1007/s00392-011-0397-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Remote Ischemic Preconditionin

Effect of Remote Ischemic Preconditioning on Acute Kidney Injury in Nondiabetic Patients Undergoing Coronary Artery Bypass Graft Surgery: A Secondary Analysis of 2 Small Randomized Trials

✍ Vinod Venugopal; Chris M. Laing; Andrew Ludman; Derek M. Yellon; Derek Hausenloy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 325 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Rationale, design and baseline character

Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: A randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery

✍ David M. Ansley; Koen Raedschelders; David D.Y. Chen; Peter T. Choi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 249 KB

A multicentre, randomized, double-blind

A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial

✍ Olivier F. Bertrand; Paul Poirier; Josep Rodés-Cabau; Stéphane Rinfret; Lawrence 📂 Article 📅 2009 🏛 Pulsus Group Inc 🌐 English ⚖ 803 KB

Effects of hyperoncotic or hypertonic–hy

Effects of hyperoncotic or hypertonic–hyperoncotic solutions on polymorphonuclear neutrophil count, elastase- and superoxide-anion production: a randomized controlled clinical trial in patients undergoing elective coronary artery bypass grafting

✍ G. P. Molter; M. Silomon; C. Bauer; S. Ziegeler; S. Soltesz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB